Valuation Trading Multiples & Precedent Transactions: Surgical Systems and Devices Manufacturers
Valuation benchmarks for Surgical Systems and Devices Manufacturers. Access public trading comps, EV/EBITDA acquisition multiples, and private market data for pitch books and valuation analysis.
1.1 - Surgical Systems and Devices Manufacturers Market Context & Valuation Drivers
Companies in this public trading comparables group design, manufacture, and market surgical systems and interventional medical devices across ophthalmology, orthopedics, cardiology, endoscopy, radiation oncology, and robotic-assisted surgery. They sell capital equipment supported by high-margin consumables and service contracts, enabling recurring revenue. Grouped for valuation benchmarks, these device makers share similar regulatory pathways, provider-focused commercial models, and procedure-driven demand profiles that underpin comparable growth and margin dynamics.
Typical capabilities include integrated surgical platforms and robotic systems, single‑use endoscopy and bronchoscopes, ophthalmic surgical tools and refractive technology, orthopedic implants for hip, knee, shoulder, and spine, cardiovascular and endovascular devices, radiation therapy and radiosurgery systems, neurosurgery instruments, wound closure and management products, and perioperative energy generators and software. Business models blend capital sales, disposable instruments, upgrades, service contracts, clinical software, training, and long‑term installed‑base support.
Primary customers are hospitals and health systems, ambulatory surgery centers, specialty clinics, and oncology centers. Key valuation drivers include procedure volume growth and installed‑base expansion, recurring consumables and service revenue mix, ASPs and operating margins, and geographic diversification. Analysts use these public trading comparables to benchmark revenue growth, margin profiles, utilization rates, and replacement cycles when assessing investment attractiveness.
2. Valuation Analysis: Public Trading Comps & Multiples for Surgical Systems and Devices Manufacturers companies
2.1 - Public Peer Groups & Median Valuation Multiples for Surgical Systems and Devices Manufacturers sector
Comparable group 1: Surgical Systems and Devices Manufacturers
Bausch Health
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of pharmaceutical products in the fields of gastroenterology, hepatology, neurology, dermatology, and other healthcare sectors, focusing on enhancing health outcomes through diversified product offerings.
- Key Products:
- Eye Health Products: Comprehensive eye care solutions through Bausch + Lomb
- Gastroenterology Medications: Treatments for digestive health issues
- Neurology Devices: Solutions for neurological conditions
- Dermatology Products: Skincare solutions addressing various conditions
- Dental Products: Instruments and solutions for dental care.
Bausch & Lomb
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of pharmaceutical and medical device solutions with a focus on eye health, gastroenterology, neurology, dermatology, and aesthetics aiming to improve global health outcomes through diverse product offerings.
- Key Products:
- Eye Health Solutions: Develops and markets products for vision care and ophthalmic health
- Gastroenterology Products: Offers pharmaceuticals for the management of gastrointestinal conditions
- Neurology Medications: Provides therapies for neurological disorders
- Dermatology Treatments: Creates dermal solutions for various skin conditions
- Aesthetic Devices: Manufactures medical devices for aesthetic enhancement.